JP5881722B2 - がん性貧血改善・予防剤 - Google Patents

がん性貧血改善・予防剤 Download PDF

Info

Publication number
JP5881722B2
JP5881722B2 JP2013538532A JP2013538532A JP5881722B2 JP 5881722 B2 JP5881722 B2 JP 5881722B2 JP 2013538532 A JP2013538532 A JP 2013538532A JP 2013538532 A JP2013538532 A JP 2013538532A JP 5881722 B2 JP5881722 B2 JP 5881722B2
Authority
JP
Japan
Prior art keywords
anemia
cancer
improving
iron
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013538532A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2013054770A1 (ja
Inventor
田中　徹
徹 田中
元夫 中島
元夫 中島
史紀 安部
史紀 安部
聡史 河田
聡史 河田
高橋　究
究 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SBI Pharmaceuticals Co Ltd
Original Assignee
SBI Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SBI Pharmaceuticals Co Ltd filed Critical SBI Pharmaceuticals Co Ltd
Priority to JP2013538532A priority Critical patent/JP5881722B2/ja
Publication of JPWO2013054770A1 publication Critical patent/JPWO2013054770A1/ja
Application granted granted Critical
Publication of JP5881722B2 publication Critical patent/JP5881722B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2013538532A 2011-10-12 2012-10-05 がん性貧血改善・予防剤 Active JP5881722B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013538532A JP5881722B2 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2011225383 2011-10-12
JP2011225383 2011-10-12
JP2012081346 2012-03-30
JP2012081346 2012-03-30
JP2013538532A JP5881722B2 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤
PCT/JP2012/076020 WO2013054770A1 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015234461A Division JP6093428B2 (ja) 2011-10-12 2015-12-01 がん性貧血改善・予防剤

Publications (2)

Publication Number Publication Date
JPWO2013054770A1 JPWO2013054770A1 (ja) 2015-03-30
JP5881722B2 true JP5881722B2 (ja) 2016-03-09

Family

ID=48081825

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013538532A Active JP5881722B2 (ja) 2011-10-12 2012-10-05 がん性貧血改善・予防剤
JP2015234461A Active JP6093428B2 (ja) 2011-10-12 2015-12-01 がん性貧血改善・予防剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015234461A Active JP6093428B2 (ja) 2011-10-12 2015-12-01 がん性貧血改善・予防剤

Country Status (7)

Country Link
US (1) US9539225B2 (enExample)
EP (1) EP2767280B1 (enExample)
JP (2) JP5881722B2 (enExample)
CN (1) CN103974702A (enExample)
HK (1) HK1200323A1 (enExample)
TW (1) TWI590823B (enExample)
WO (1) WO2013054770A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2767277B1 (en) 2011-10-12 2018-11-28 SBI Pharmaceuticals Co., Ltd. Treatment agent and/or prophylactic agent for side effects of cancer drugs
JP6177343B2 (ja) * 2013-10-29 2017-08-09 学校法人東京農業大学 フラタキシン増強剤
US10675242B2 (en) 2016-09-02 2020-06-09 Sbi Pharmaceuticals, Co., Ltd. Aqueous formulation containing 5-aminolevulinic acid or the like
JP2024006280A (ja) 2022-07-01 2024-01-17 ネオファーマジャパン株式会社 安定性に優れた非水性製剤
CN116036232A (zh) * 2023-02-09 2023-05-02 山东深海生物科技股份有限公司 一种含5-氨基乙酰丙酸或其衍生物的安神助眠药剂及制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754731B2 (ja) 2001-07-31 2011-08-24 コスモ石油株式会社 豚成育促進剤及び豚成育促進方法
JP5295652B2 (ja) 2008-06-16 2013-09-18 Ｓｂｉファーマ株式会社 光障害の軽減剤
US9095165B2 (en) * 2008-10-27 2015-08-04 Sbi Pharmaceuticals Co., Ltd. Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
JP5611548B2 (ja) * 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
JP5648120B2 (ja) * 2010-03-23 2015-01-07 ヴィフォール （インターナショナル） アクチェンゲゼルシャフトＶｉｆｏｒ （Ｉｎｔｅｒｎａｔｉｏｎａｌ） ＡＧ 鉄欠乏症および鉄欠乏性貧血の治療および予防用の鉄（ｉｉｉ）錯体化合物
US9018257B2 (en) * 2011-03-24 2015-04-28 Bar Ilan University 5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
CN108403678A (zh) * 2011-10-12 2018-08-17 思佰益药业股份有限公司 慢性肾脏病的改善、预防剂

Also Published As

Publication number Publication date
HK1200323A1 (en) 2015-08-07
EP2767280A4 (en) 2015-04-08
TW201320995A (zh) 2013-06-01
JPWO2013054770A1 (ja) 2015-03-30
EP2767280C0 (en) 2024-05-22
WO2013054770A1 (ja) 2013-04-18
JP6093428B2 (ja) 2017-03-08
US9539225B2 (en) 2017-01-10
US20140288173A1 (en) 2014-09-25
EP2767280A1 (en) 2014-08-20
JP2016033160A (ja) 2016-03-10
EP2767280B1 (en) 2024-05-22
TWI590823B (zh) 2017-07-11
CN103974702A (zh) 2014-08-06

Similar Documents

Publication Publication Date Title
JP5881721B2 (ja) 慢性腎臓病の改善・予防剤
JP6093428B2 (ja) がん性貧血改善・予防剤
JP6051283B2 (ja) 抗ガン剤の副作用の予防剤及び／又は治療剤
JP5818905B2 (ja) エリスロポエチン産生促進剤
HK1196002A (en) Anemia of cancer improving/prophylactic agent
HK1196002B (en) Anemia of cancer improving / prophylactic agent
HK1196003B (en) Treatment agent and/or prophylactic agent for side effects of cancer drugs
HK1202259B (en) Erythropoietin production-promoting agent
HK1196003A (en) Treatment agent and/or prophylactic agent for side effects of cancer drugs
HK1195879A (en) Improving / prophylactic agent for chronic kidney disease
HK1195879B (en) Improving / prophylactic agent for chronic kidney disease

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150525

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150615

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151201

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20151210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160125

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160202

R150 Certificate of patent or registration of utility model

Ref document number: 5881722

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250